WHO/Yoshi Shimizu
© Credits

Rotavirus infections

    Overview

    Rotavirus is the most common cause of severe diarrhoeal disease in infants and young children globally. It is transmitted through the oral-faecal route, directly from person to person, or indirectly through contaminated objects. People that are infected experience an abrupt onset of fever and vomiting followed by explosive, watery diarrhoea. Rotavirus diarrhoea is profuse, often leading to dehydration which can be severe, requiring hospitalization. The cornerstones of treatment of severe rotavirus diarrhoea are fluid replacement and zinc supplementation. 

    Vaccines against rotavirus are available and vaccination is an important measure to reduce severe rotavirus-associated diarrhoea and mortality. 

    Symptoms

    Rotavirus causes watery diarrhoea, vomiting and severe dehydration in young children. Rotavirus diarrhoea is ubiquitous and, unlike bacterial diarrhoea, is not more prevalent in settings with poor water, sanitation and hygiene. Rotavirus peaks in cool, dry seasons in temperate climates but exhibits less pronounced seasonality in tropical settings. 

    The clinical spectrum of rotavirus disease is wide, ranging from transient loose stools to severe diarrhoea and vomiting causing dehydration, electrolyte disturbances, shock, and death if rehydration is not provided. In typical cases, following an incubation period of 1–3 days, the onset of disease is abrupt, with fever and vomiting followed by watery diarrhoea. Gastrointestinal symptoms normally resolve within 3–7 days but may last for up to 2–3 weeks. 

    Rotavirus has a case-fatality rate of approximately 2.5% among children in low-income countries who present to health facilities. This rate is higher in areas without good access to health care. 

    Prevention

    WHO prequalified rotavirus vaccines have been available from 2008 and there are currently four vaccines available. They are all live, oral vaccines. RotaTeq, Rotavac, and ROTASIIL should be administered in a 3-dose schedule, while a 2-dose schedule should be used for Rotarix. A minimum interval of 4 weeks should be maintained between doses.

    WHO recommends that rotavirus vaccines should be included in all national immunization programmes and considered a priority, particularly in countries with high rotavirus gastroenteritis-associated fatality rates, such as in South and South-eastern Asia and sub-Saharan Africa.

    In addition, key measures to prevent diarrhoea include the following:

    • access to safe drinking-water
    • use of improved sanitation
    • hand washing with soap
    • exclusive breastfeeding for the first six months of life
    • good personal and food hygiene
    • health education about how infections spread

    Featured publications

    All →
    Immunization program data: regional and country profiles 2022

    This publication includes regional and national trends on vaccine-preventable disease cases and immunization coverage in the Western Pacific Region as...

    32nd Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region, 20-23 June 2023, Manila, Philippines/Hybrid: meeting report

    The 32nd Meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine-Preventable Diseases in the World Health Organization (WHO) Western...

    Regional strategic framework for vaccine-preventable diseases and immunization in the Western Pacific 2021-2030

    The WHO’s Regional Committee for the Western Pacific endorsed the Regional Strategic Framework for Vaccine-Preventable Diseases (‎VPDs)‎...

    Rotavirus vaccines: WHO position paper - July 2021

    This position paper replaces the 2013 WHO position paper on rotavirus vaccines; it adds recent developments in the field, such as 2 additional rotavirus...

    Our work